tiprankstipranks
Trending News
More News >
Liminatus Pharma, Inc. (LIMN)
:LIMN
US Market

Liminatus Pharma (LIMN) Financial Statements

Compare
57 Followers

Liminatus Pharma Financial Overview

Liminatus Pharma's market cap is currently $21.38M. The company's EPS TTM is $; its P/E ratio is -4.26; Liminatus Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Liminatus Pharma Earnings and Revenue History

Liminatus Pharma Debt to Assets

Liminatus Pharma Cash Flow

Liminatus Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.